FDA panel backs COVID-19 booster shots only for elderly and high-risk Americans

By: - September 17, 2021 6:04 pm
Gray Pfizer sign on company headquarters in New York City.

All but two of the panel’s 18 voting members rejected Pfizer’s request that the company be allowed to offer extra doses to anyone 16 and older, six months after their second dose. (Getty Images)

Our stories may be republished online or in print under Creative Commons license CC BY-NC-ND 4.0. We ask that you edit only for style or to shorten, provide proper attribution and link to our web site. Please see our republishing guidelines for use of photos and graphics.

Laura Olson
Laura Olson

Laura covers the nation's capital as a senior reporter for States Newsroom, a network of nonprofit outlets that includes Ohio Capital Journal. Her areas of coverage include politics and policy, lobbying, elections, and campaign finance.

MORE FROM AUTHOR